Cho Dennis sold $1.3M of TWST
Cho Dennis (See Remarks) sold 14,205 shares of Twist Bioscience Corp (TWST) at $89.75 ($1.27M total) on 2026-06-24 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The only new information is the specific sale size, price, and post-transaction holdings under a 10b5-1 plan; it does not include any new company performance, guidance, or regulatory developments.
Market read
Traders may note the insider selling activity, but the 10b5-1 structure and lack of fundamental updates make it low-conviction for directional trading.
What to watch
The article does not state whether other insiders sold/bought around the same window, nor does it provide context on total planned volume or remaining plan size.
Background
The article is a SEC Form 4 insider transaction disclosure for Twist Bioscience, reported via SEC EDGAR.
Ticker impact
Twist Bioscience insider Dennis Cho filed a Form 4 open-market sale of 14,205 shares at $89.75 on June 24 under a 10b5-1 plan.
Likely minimal price impact; any effect is short-lived and sentiment-driven rather than fundamental.
The filing is an open-market sale under a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed in the text.
Market effects
No clear sector read-through from a single routine insider sale disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is on a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations, so traders may discount it.
Key entities
- issuerTwist Bioscience Corp
Subject of the Form 4 insider transaction disclosure.
- insiderDennis Cho
Officer who executed the open-market sale under a pre-arranged 10b5-1 plan.
